Harbor Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$302K Hold
252
0.04% 95
2026
Q1
$231K Buy
252
+1
+0.4% +$1.01K 0.03% 108
2025
Q4
$270K Buy
+251
New +$240K 0.04% 99
2025
Q2
Sell
-250
Closed -$207K 102
2025
Q1
$207K Buy
+250
New +$208K 0.04% 93
2024
Q4
Sell
-250
Closed -$222K 95
2024
Q3
$222K Hold
250
0.05% 85
2024
Q2
$226K Buy
+250
New +$200K 0.06% 78
2021
Q2
Sell
-1,258
Closed -$235K 51
2021
Q1
$235K Hold
1,258
0.16% 45
2020
Q4
$233K Buy
+1,258
New +$188K 0.17% 45

Other funds holding LLY

Harbor Group's LLY Position: Q2 2026 in Review

Harbor Group held its Eli Lilly (LLY) position steady in Q2 2026 at 252 shares worth $302K. The position accounts for 0.04% of the portfolio, ranked #95.

Harbor Group first reported a position in LLY in Q4 2020 and has held it in 8 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Harbor Group held 252 shares of Eli Lilly worth $302K as of Q2 2026.
  • Harbor Group left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.04% of Harbor Group's portfolio in Q2 2026, its #95 holding.
  • Harbor Group first reported a position in Eli Lilly in Q4 2020 and has held it in 8 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Harbor Group's 13F filing for Q2 2026, filed 22 Jul 2026.